1. GPCR/G Protein
  2. P2Y Receptor
  3. Denufosol tetrasodium

Denufosol tetrasodium (Synonyms: INS37217)

Cat. No.: HY-U00196
Handling Instructions

Denufosol tetrasodium (INS37217) is a long-acting P2Y2 receptor agonist, which exhibits an EC50 of ~10 μM for P2Y2 receptor activation.

For research use only. We do not sell to patients.

Denufosol tetrasodium Chemical Structure

Denufosol tetrasodium Chemical Structure

CAS No. : 318250-11-2

Size Stock
100 mg   Get quote  
250 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

Top Publications Citing Use of Products
  • Biological Activity

  • Protocol

  • Purity & Documentation

  • References

  • Customer Review

Description

Denufosol tetrasodium (INS37217) is a long-acting P2Y2 receptor agonist, which exhibits an EC50 of ~10 μM for P2Y2 receptor activation[1].

IC50 & Target

EC50: 10 μM (P2Y2 receptor)[1]

In Vitro

Denufosol tetrasodium can be maintained above the EC50 point for 6 to 8 hours on the airway surface of airway cultures. Denufosol produces a significant increase in airway surface layer (ASL) height, reflecting P2Y2 receptor–mediated fluid secretion, which is terminated rapidly, likely reflecting P2Y2 receptor desensitization. The secreted ASL is reabsorbed over time, despite the continued presence of Denufosol at values exceeding its EC50, albeit at a rate slower than without Denufosol exposure (compared to vehicle group). This latter finding is consistent with the observation that P2Y2 receptor-mediated inhibition of Na+ absorption may persist for larger intervals than P2Y2 receptor activation of Cl- secretion[1]. Denufosol (INS37217) is a deoxycytidine-uridine dinucleotide with agonist activity at the P2Y2 receptor. In a concentration-dependent manner, Denufosol induces the mobilization of intracellular calcium in 1321N1 astrocytoma cells stably expressing human P2Y2 and P2Y4 receptors with EC50s of 0.22 and 0.8 μM, respectively. The efficacy of Denufosol is identical to that of UTP, indicating that Denufosol is a full agonist of P2Y2 and P2Y4 receptors. Denufosol is a weak agonist of P2Y6 receptors in which 100 μM Denufosol produces approximately 70% of the response observed with the natural agonist UDP[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

The P2Y2 receptor agonist Denufosol (INS37217) improves the rate of retinal reattachment in animal models of induced retinal detachment (RD), and has been shown to also significantly enhance the rate of ERG recovery in a mouse model of RD. The identification of genes modulated by Denufosol may allow further drug discovery for treating RD and edema. RD is induced in Balb/cJ mice by transvitreal subretinal injections of 1 μL saline or of 1 μL of 10 μM Denufosol/saline to cause detachment and to expedite the rate of recovery[3].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

861.25

Formula

C₁₈H₂₃N₅Na₄O₂₁P₄

CAS No.
SMILES

O[[email protected]]1[[email protected]@H](O[[email protected]@H]([[email protected]]1O)COP(OP(OP(OP(OC[[email protected]]2O[[email protected]](C[[email protected]@H]2O)N3C(N=C(C=C3)N)=O)(O[Na])=O)(O[Na])=O)(O[Na])=O)(O[Na])=O)N4C(NC(C=C4)=O)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
References
Animal Administration
[3]

Mice[3]
Balb/cJ mice are used for microarray experiments. Subretinal injections are performed. Briefly, 1 μL saline or 1 μL saline/10 μM Denufosol is delivered to the subretinal space in Balb/cJ mice by transvitreal injection. This procedure creates a retinal hole that is self-sealing because material delivered will not diffuse into the vitreous. Mock injections consisting solely of a corneal puncture with no RD are also performed as a control. Mice are humanely killed at 2 hours, 24 hours, or 7 days after injection, and their retinas are harvested directly into reagent. For each time point, three separate pools of at least five retinas are collected for saline- and Denufosol -injected mice. After tissue homogenization, total RNA is isolated and is purified by a method for total isolation of RNA[3].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Keywords:

Denufosol tetrasodiumINS37217INS 37217INS-37217P2Y ReceptorlongactingP2Y2Inhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email address *

Phone number *

 

Organization name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Denufosol tetrasodium
Cat. No.:
HY-U00196
Quantity:
MCE Japan Authorized Agent: